Questions and answers

What is cancer recurrence and how is it followed up?

Why cancer comes back, the types of recurrence, the follow-up plan after treatment and what the evidence says about follow-up tests

Updated: 28 October 20262 min read7 references
Show content for:
Short answer

Cancer recurrence means the cancer coming back after treatment; it comes from a small number of cancer cells that survived the first treatment and were too small to be seen on follow-up tests, and it does not mean the earlier treatment was wrong [1]. A recurrence may be local (in the same place), regional (in lymph nodes or nearby tissue) or distant (metastatic) [1]. Follow-up is usually a visit every 3 to 4 months for the first 2 to 3 years and then once or twice a year, but the exact plan depends on the type of cancer, the treatment and the person's health [2].

Key points

  • In oestrogen receptor-positive breast cancer, after 5 years of hormone therapy, recurrences continued at a steady rate from year 5 to year 20 [3].
  • Treatments may have advanced since the first cancer, and in some cases recurrent cancer has become a chronic, controllable disease [1].

Why does cancer come back?

Recurrent cancer starts from cancer cells that the first treatment could not destroy completely. This does not mean the treatment was wrong; it just means a few cells survived that were too small to be seen on follow-up tests and gradually grew into a detectable tumour [1].

Types of cancer recurrence [1]
Type of recurrenceWhat it meansExample
LocalThe cancer is in the same place as the original cancer or very close to itCancer coming back in the treated breast
RegionalThe tumour has reached lymph nodes or tissue near the original cancerInvolvement of nearby lymph nodes
DistantThe cancer has spread to distant organs or tissues (metastasis)Colon cancer that recurs in the liver and is still called "colon cancer"

What is follow-up after treatment like?

All cancer survivors should have regular follow-up and, at the end of treatment, receive a "follow-up plan" including a summary of treatment and further recommendations. How often you are seen depends on the type of cancer, the treatment received and your general health; in general, visits are every 3 to 4 months for the first 2 to 3 years and then once or twice a year. At these visits you are examined and, if needed, have blood tests and other checks [2].

Questions worth asking your doctor: which symptoms should I watch for? Which tests are needed, and how often? What long-term side effects might I have? How likely is my cancer to come back? [2]

For physiciansWhat trials and guidelines say about how intensive follow-up should be · Specialist notes
For physicians
What trials and guidelines say about how intensive follow-up should be
CancerSourceFinding or recommendation
BreastASCO guidelineExamination every 3 to 6 months for the first 3 years, every 6 to 12 months in years 4 and 5, then yearly; yearly mammography; blood tests, bone scans, CT, PET, MRI and tumour markers are not recommended routinely in a patient without symptoms [4]
ColorectalFACS trial (1202 patients)Follow-up with CEA or CT increased the proportion of recurrences treated surgically with curative intent (6.7% to 8% vs 2.3%), but the number of deaths did not differ significantly [5]
Stage 2 and 3 colorectalCOLOFOL trial (2509 patients)5-year mortality was 13.0% with high-frequency follow-up and 14.1% with low-frequency follow-up; the difference was not significant [6]
For physicians

In some cancers the risk of recurrence persists for years. In a meta-analysis of 88 trials with 62,923 women with oestrogen receptor-positive breast cancer who were disease-free after 5 years of hormone therapy, the risk of distant recurrence over years 5 to 20 ranged from 10% to 41% depending on tumour size and the number of involved lymph nodes; for example 13% for small node-negative tumours and 41% for T2 tumours with 4 to 9 involved nodes [3].

What happens if the cancer comes back?

Many of the same tests done at diagnosis are repeated to find the site and extent of spread ("restaging"), and a new stage with the prefix "r" may be assigned, but the original stage does not change. Treatment options include surgery, chemotherapy, radiotherapy, biological therapies or a combination of these, and clinical trials, and palliative care is always available [1].

When should I call my doctor?

Ask your doctor which symptoms matter for your type of cancer [2]. In general, report any new symptom that persists; for example, metastasis may show itself through bone pain or a fracture, headache, seizures or dizziness, shortness of breath, or jaundice and swelling of the abdomen [7].

Related questions

Does recurrence mean the earlier treatment was wrong?

No. Recurrence means that a small number of cancer cells survived treatment and were too small to be seen [1].

Do more tests and scans help people live longer?

Not necessarily. In bowel cancer, more intensive follow-up with CT and CEA did not significantly reduce mortality [5, 6], and in breast cancer, routine scans and tumour markers are not recommended in patients without symptoms [4].

What is the difference between a recurrence and a second cancer?

A recurrence is the same cancer coming back; but sometimes a person who has had cancer develops a new type of cancer, which is called a "second primary cancer" [1].

Related cancer types

References

7 references
Show all references, 4 with a study cardClose the reference list

Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.

  1. 1
    Recurrent Cancer: When Cancer Comes BackNational Cancer Institute · cancer.gov · 2025
    Source Back to text: 1 2 3 4 5 6 7 8
  2. 2
    Follow-Up Medical CareNational Cancer Institute · cancer.gov · 2024
    Source Back to text: 1 2 3 4
  3. 3
    20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 YearsPan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, et al · N Engl J Med · 2017;377:1836-1846
    Study cardDOIPubMed Back to text: 1 2
  4. 4
    Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline UpdateKhatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, et al · JCO · 2013;31:961-965
    Study cardDOIPubMed Back to text: 1 2
  5. 5
    Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal CancerPrimrose JN, Perera R, Gray A, Rose P, Fuller A, Corkhill A, et al · JAMA · 2014;311:263
    Study cardDOIPubMed Back to text: 1 2
  6. 6
    Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer–Specific Mortality in Patients With Stage II or III Colorectal CancerWille-Jørgensen P, Syk I, Smedh K, Laurberg S, Nielsen DT, Petersen SH, et al · JAMA · 2018;319:2095
    Study cardDOIPubMed Back to text: 1 2
  7. 7
    Metastatic Cancer: When Cancer SpreadsNational Cancer Institute · cancer.gov · 2026

This page is based on reputable scientific sources and was last updated on 28 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.